Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 191

    1.

    Marked liver tumorigenesis by Helicobacter hepaticus requires perinatal exposure.

    Diwan BA, Sipowicz M, Logsdon D, Gorelick P, Anver MR, Kasprzak KS, Anderson LM.

    Environ Health Perspect. 2008 Oct;116(10):1352-6. Epub 2008 Jun 13.PMID: 18941577 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species.

    Ward JM, Fox JG, Anver MR, Haines DC, George CV, Collins MJ Jr, Gorelick PL, Nagashima K, Gonda MA, Gilden RV, et al.

    J Natl Cancer Inst. 1994 Aug 17;86(16):1222-7.PMID: 8040890 [PubMed - indexed for MEDLINE]Related articles

    4.

    Promotion by Helicobacter hepaticus-induced hepatitis of hepatic tumors initiated by N-nitrosodimethylamine in male A/JCr mice.

    Diwan BA, Ward JM, Ramljak D, Anderson LM.

    Toxicol Pathol. 1997 Nov-Dec;25(6):597-605.PMID: 9437805 [PubMed - indexed for MEDLINE]Related articles

    5.

    Helicobacter hepaticus infection promotes colon tumorigenesis in the BALB/c-Rag2(-/-) Apc(Min/+) mouse.

    Nagamine CM, Sohn JJ, Rickman BH, Rogers AB, Fox JG, Schauer DB.

    Infect Immun. 2008 Jun;76(6):2758-66. Epub 2008 Apr 14.PMID: 18411292 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Age-related alterations in 32P-postlabeled DNA adducts in livers of mice infected with the tumorigenic bacterial pathogen, Helicobacter hepaticus.

    Josyula S, Schut HA, Diwan BA, Anver MR, Anderson LM.

    Int J Oncol. 2000 Oct;17(4):811-8.PMID: 10995896 [PubMed - indexed for MEDLINE]Related articles

    7.

    Chronic proliferative hepatitis in A/JCr mice associated with persistent Helicobacter hepaticus infection: a model of helicobacter-induced carcinogenesis.

    Fox JG, Li X, Yan L, Cahill RJ, Hurley R, Lewis R, Murphy JC.

    Infect Immun. 1996 May;64(5):1548-58.PMID: 8613359 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Alteration in cell kinetics in control B6C3F1 mice infected with Helicobacter hepaticus.

    Nyska A, Maronpot RR, Eldridge SR, Haseman JK, Hailey JR.

    Toxicol Pathol. 1997 Nov-Dec;25(6):591-6.PMID: 9437804 [PubMed - indexed for MEDLINE]Related articles

    9.

    Lack of p53 and ras mutations in Helicobacter hepaticus-induced liver tumors in A/JCr mice.

    Sipowicz MA, Weghorst CM, Shiao YH, Buzard GS, Calvert RJ, Anver MR, Anderson LM, Rice JM.

    Carcinogenesis. 1997 Jan;18(1):233-6.PMID: 9054612 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    SCID/NCr mice naturally infected with Helicobacter hepaticus develop progressive hepatitis, proliferative typhlitis, and colitis.

    Li X, Fox JG, Whary MT, Yan L, Shames B, Zhao Z.

    Infect Immun. 1998 Nov;66(11):5477-84.PMID: 9784560 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Progression of chronic hepatitis and preneoplasia in Helicobacter hepaticus-infected A/JCr mice.

    Rogers AB, Boutin SR, Whary MT, Sundina N, Ge Z, Cormier K, Fox JG.

    Toxicol Pathol. 2004 Nov-Dec;32(6):668-77.PMID: 15513910 [PubMed - indexed for MEDLINE]Related articles

    12.

    Pathogenesis of mouse hepatitis virus infection in gamma interferon-deficient mice is modulated by co-infection with Helicobacter hepaticus.

    Compton SR, Ball-Goodrich LJ, Zeiss CJ, Johnson LK, Johnson EA, Macy JD.

    Comp Med. 2003 Apr;53(2):197-206.PMID: 12784855 [PubMed - indexed for MEDLINE]Related articles

    13.

    Optimal age at fostering for derivation of Helicobacter hepaticus-free mice.

    Singletary KB, Kloster CA, Baker DG.

    Comp Med. 2003 Jun;53(3):259-64.PMID: 12868570 [PubMed - indexed for MEDLINE]Related articles

    14.

    Long-term colonization levels of Helicobacter hepaticus in the cecum of hepatitis-prone A/JCr mice are significantly lower than those in hepatitis-resistant C57BL/6 mice.

    Whary MT, Cline J, King A, Ge Z, Shen Z, Sheppard B, Fox JG.

    Comp Med. 2001 Oct;51(5):413-7.PMID: 11924800 [PubMed - indexed for MEDLINE]Related articles

    15.

    Comparison of methods of identifying Helicobacter hepaticus in B6C3F1 mice used in a carcinogenesis bioassay.

    Fox JG, MacGregor JA, Shen Z, Li X, Lewis R, Dangler CA.

    J Clin Microbiol. 1998 May;36(5):1382-7.PMID: 9574710 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Modulation of host immune responses by the cytolethal distending toxin of Helicobacter hepaticus.

    Pratt JS, Sachen KL, Wood HD, Eaton KA, Young VB.

    Infect Immun. 2006 Aug;74(8):4496-504.PMID: 16861635 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Natural history of Helicobacter hepaticus infection in conventional A/J mice, with special reference to liver involvement.

    Avenaud P, Le Bail B, Mayo K, Marais A, Fawaz R, Bioulac-Sage P, Megraud F.

    Infect Immun. 2003 Jun;71(6):3667-72.PMID: 12761159 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Persistent hepatitis and enterocolitis in germfree mice infected with Helicobacter hepaticus.

    Fox JG, Yan L, Shames B, Campbell J, Murphy JC, Li X.

    Infect Immun. 1996 Sep;64(9):3673-81.PMID: 8751916 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Sex influence on chronic intestinal inflammation in Helicobacter hepaticus-infected A/JCr mice.

    Livingston RS, Myles MH, Livingston BA, Criley JM, Franklin CL.

    Comp Med. 2004 Jun;54(3):301-8.PMID: 15253277 [PubMed - indexed for MEDLINE]Related articles

    20.

    Helicobacter hepaticus promotes azoxymethane-initiated colon tumorigenesis in BALB/c-IL10-deficient mice.

    Nagamine CM, Rogers AB, Fox JG, Schauer DB.

    Int J Cancer. 2008 Feb 15;122(4):832-8.PMID: 17957786 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data